BridgeBio has surged 90% since April 2025, driven by major clinical trial successes and robust commercial execution. BBIO's BBP-418 and Encaleret trials both exceeded expectations, each targeting ...
Dozens of Clients Already Operate RAD Firearm Detection and New Third Party Compatibility Extends Reach to Tens of Millions of Cameras "For too long the costs for this category of solution have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback